Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Sonia Yoo, Bascom Palmer Eye Institute
ClinicalTrials.gov Identifier:
NCT00769145
First received: October 7, 2008
Last updated: July 24, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)